首页> 外文会议>European Macula Group >. Blood-retinal barrier and new perspectives ofmanagement of retinal disease
【24h】

. Blood-retinal barrier and new perspectives ofmanagement of retinal disease

机译:。血压屏障和视网膜疾病管理的新观点

获取原文

摘要

The most important function of the blood-retinal barrier (BRB) is maintenance of the homeostasis of the retina environment by separating the retina from the systemic blood circulation. The organization of the BRB is such that the retina is protected from blood-borne compounds, since a strict homeostasis of the neuronal environment and an intact barrier are essential for optimal retina functioning. For treatment of diseases involving the retina, drugs must pass the BRB in a significant amount to have therapeutic effect. Drug entry into the retina, must take into account the plasma concentration profile of the drug, the volume of its distribution, the rate of metabolism of the drug, its plasma protein binding and the relative permeability of the BRB for that drug. All parameters affect the therapeutic efficacy of the drug and are also relevant for potential side effects.In order to obtain therapeutic drug concentrations within the retina, several drug delivery strategies are under current investigation, opening new perspectives for more efficient management of retinal disease.
机译:血质视网膜屏障(BRB)最重要的功能是通过将视网膜分离从系统性血液循环来维持视网膜环境的稳态。 BRB的组织使得视网膜受到血流化合物的保护,因为神经元环境的严格稳态和完整的屏障对于最佳视网膜功能是必不可少的。为了治疗涉及视网膜的疾病,药物必须以显着的量通过BRB以具有治疗效果。药物进入视网膜,必须考虑药物的血浆浓度曲线,其分布的体积,药物代谢率,其血浆蛋白结合和该药物的BRB的相对渗透性。所有参数影响药物的治疗效果,也与潜在的副作用相关。为了在视网膜内获得治疗药物浓度,在当前调查下,几种药物输送策略正在开启新的视角,以更有效的视网膜疾病管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号